Bristol Myers Squibb’s Post

Join us this week in Boston! If you are attending #OCTNewEngland be sure to say hello to Dia Dooley, Joe Statts, and Darby Miller at booth 16! See where we are heading next: https://hubs.la/Q02T-8tl0 #OutsourcinginClinicalTrials #ClinChoice #ClinChoiceCanHelp #ContractResearchOrganization #LifeSciences #ClinicalResearch #ClincalTrials

My main takeaways from another amazing Dermsquared #FallClinical: 1) The dermatology pipeline is immense. Numerous novels MoAs are incoming for #HidradenitisSuppurativa #AtopicDermatitis and #ChronicSpontaneousUrticaria. While big Pharma including most notably Sanofi Eli Lilly and Company AbbVie Incyte Johnson & Johnson Novartis and Takeda have many Ph2-Ph3 assets, a plethora of smaller biotech interests including, but certainly not limited, to Alumis Apogee Therapeutics Oruka Therapeutics Q32 Bio Inc. Celldex Therapeutics MoonLake Immunotherapeutics (NASDAQ: MLTX) AnaptysBio are also involved. 2) "The Year of the JAK" Since it may be a while until many of the these assets can make it to the finish line, we need to utilize what we have available right now for our patients (which is still pretty good!). I heard Dr. Theodore Rosen call this the "The Year of the JAK" and I couldn't agree more. Janus kinase inhibitors are being used more and more as dermatology providers come to the realization that these therapies can be used with a high degree of safety with proper patient selection and counseling. As these therapies get approved for more conditions of unmet need (i.e. Rinvoq in #vitiligo and #alopeciaareata, povorcitinib in #HS), our patients will expect us to be competent in prescribing these oral small molecules. 3) We are so blessed to be in dermatology. Not just dermatologists, but all of us including our industry colleagues, advanced practice providers, biologics coordinators, medical assistants, front office staff, and everyone else... our patients for the most part are doing well and on good therapies, and I've developed so many friendships across the dermatology ecosystem for which I'm very grateful.

We need more leaders like Colton Storla, CPBS, GBDS • Matt Ohrt • Andy Niemi • Lee Aase who operate from an abundance mindset. Leaders with an abundance mindset see others in their field as collaborators because they understand how working together can expand the market and create more opportunities for everyone, rather than competing for a limited share. Grow the category. Grow your business. Tag the leaders you work with that bring an abundance mindset. Free Market Medical Association • Health Rosetta • Kynexions

A great panel discussion on Unlocking your Leadership Journey. #ILDA #ILDAspringmeeting #laboratoryequipment #laboratory #laboratorysupplies #distributors #manufacturers #networking #networkingevent

👏 👏 👏 PEER REVIEW WEEK! 👏 👏 👏 Cheers to all my fellow reviewers and Cosmetics & Toiletries for their commitment to the peer review process! Peer review serves as a critical quality control mechanism, ensuring that published studies meet rigorous standards of methodology, analysis, and interpretation. By subjecting manuscripts to expert scrutiny, peer review helps identify flaws, errors, or biases that may have been overlooked by the authors, ultimately improving the overall quality of the work. This process not only validates research findings but also enhances the credibility and trustworthiness of scientific literature, which is essential for building public confidence in academic research. #cosmeticscience #cosmeticchemist #businessofbeauty

In our latest episode of At the Intersection of Science and Law, Quest Diagnostics' Adam Donat joins DLA Piper's Kirsten Axelsen, Rachel (Soclof) Portman, and Jae Kim to discuss the growing complexities of clinical trials and additional considerations for trial sponsors: https://lnkd.in/gwi3J39j #LifeSciences #ClinicalTrials #Diversity

🚨 🔊 ICYMI 🔊 🚨 Just recently our Co-Founder Oscar Gonzalez, M.S., MBA, LSSBB sat down with Alex Guardiola, President and CEO of Better Business Bureau of Central New England and Hank Stolz of Radio Worcester 🎙️ to talk about Sigma Lab Consulting, its beginnings, and the value it brings to the biopharma space. Take a listen to the clip below!

Meltem Ozdemir (class of '22) discusses her time at Brandywine, what led her to pharmacy school and more in her alumni spotlight. Read more about Meltem: https://ow.ly/Cm1Q50Sh8xZ

The Ducks are number one! No one really thought that this could happen. 🦆 They had been close before when part of the Pac12 conference 🦆 They were now in the BIG10 conference, competing with Ohio State, Michigan and other powerhouse teams 🦆 Their chance for success this year was around 50% in some people’s minds The Head Coach believed in the team and was clear on their plan 🦆 Show everyone that they belonged in this conference 🦆 Show up and focus on each game as a team 🦆 Learn from the game they just played to make the next one better 🦆 Play for the championship The plan was a success! The Ducks 🏆 Are ranked number one in college football, with a 13-0 season 🏆 Won the Big10 conference 🏆 Are in the quarterfinals for the College Football Playoffs That’s nice, but what does this have to do with drug development? In drug development, like college football, companies that have a new drug they want to develop need to have a plan for success. They need to 🏆 Show that the drug is safe and that it works 🏆 Understand the plan and show up as a team 🏆 Adjust the plan based on data 🏆 Determine how to make the drug successful commercially As the Head Coaches (Chief Medical Officers, Heads of R&D, Pharma CEO’s, etc), do you have a plans that will get you to the championship (commercialization) and beyond? Let's connect! ***************************************************************************** Hi! My name is Wendi Carroll and I partner with biopharma companies to transform today’s trials into tomorrow’s therapies. Click on “Book an Appointment” ☝ and let’s have a conversation. Picture courtesy of Ilene Morrisette

Last week, VSA Vice President Leslee Gilbert spoke at the UIDP Bay Area Forum 2025, held this year at the global headquarters of @Synopsys Inc in Sunnyvale, CA. Dr Gilbert delivered remarks on the current trends in federal research funding and models for coordinating R&D resources to maximize impact. Attendees discussed ways to strengthen and modernize university-industry partnerships to drive research and innovation, to the benefit of society.  #UIDP #vanscoyocassociates